Elevated ghrelin levels in preterm born children during prepubertal ages and relationship with catch-up growth

Feyza Darendeliler1, Firdevs Bas, Ruveyde Bundak

  • 1Department of Pediatrics, Istanbul Faculty of Medicine, Istanbul University, 34390 Istanbul, Turkey. feyzad@istanbul.edu.tr

Insights

Preterm children exhibit elevated ghrelin levels in prepuberty, irrespective of catch-up growth (CUG). Term small for gestational age (SGA) infants show lower ghrelin, potentially linked to higher insulin levels.

Area of Science:

  • Pediatric Endocrinology
  • Growth and Development
  • Metabolic Research

Background:

  • Ghrelin, a key hormone regulating appetite and growth, plays a role in postnatal development.
  • Ghrelin levels are influenced by nutritional status and gestational age, impacting early childhood growth trajectories.
  • Understanding ghrelin's role in preterm infants is crucial for assessing their long-term growth and metabolic health.

Purpose of the Study:

  • To investigate ghrelin and insulin levels in prepubertal children born preterm, categorized as appropriate for gestational age (AGA) or small for gestational age (SGA).
  • To examine the relationship between these hormone levels and catch-up growth (CUG) in preterm children.
  • To compare these findings with term-born children (AGA and SGA) to establish normative data and identify specific patterns.

Main Methods:

  • A prospective cross-sectional study involving 84 preterm children (SGA and AGA) and BMI-matched term children (SGA and AGA).
  • Hormonal assessment of ghrelin and insulin levels at approximately 4.7 years of age.
  • Catch-up growth (CUG) quantified using Delta height and Delta weight SDS, comparing birth size to recent anthropometric measurements.

Main Results:

  • Preterm children (SGA and AGA) demonstrated significantly higher ghrelin levels compared to term-born children (SGA and AGA).
  • Ghrelin levels were similar between preterm SGA and AGA groups, despite greater CUG in preterm SGA infants.
  • Term SGA children exhibited elevated insulin levels compared to all other groups, with no significant correlation found between ghrelin and CUG.

Conclusions:

  • Preterm children maintain elevated ghrelin levels during prepuberty, independent of their catch-up growth status.
  • Term SGA children display distinct hormonal profiles with lower ghrelin and higher insulin levels compared to preterm infants.
  • These findings highlight differential hormonal regulation in SGA infants based on gestational age, with implications for growth and metabolic programming.
Abstract

Related Concept Videos

Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience, such as differences...
Signs of Puberty01:27

Signs of Puberty

Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
Regulation of Food Intake01:30

Regulation of Food Intake

Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Gastric Emptying01:16

Gastric Emptying

Gastric emptying occurs when the stomach gradually releases chyme into the duodenum. When the stomach is distended, it triggers the release of gastrin, a hormone that promotes gastric acid secretion to aid in digestion. Additionally, stomach distension contributes to peristaltic waves that propel gastric contents toward the pyloric region. The gastroenteric reflex, on the other hand, primarily stimulates peristalsis in the intestines, facilitating the movement of contents further along the...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...